Green Light for Cancer Immunotherapies in Europe Green Light for Cancer Immunotherapies in Europe

The EU authorities have recommended for approval pembrolizumab for melanoma, nivolumab for lung cancer, and dinutuximab for neuroblastoma. News Alerts
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news